In melanoma, DCs—through the wnt5a-β-catenin-PPARg signaling pathway—can upregulate the expression of FA transport protein carnitine palmitoyl transferase-1a (CPT1A), driving the FAO process and protumor effects [44]. This evidence concerns the gene CPT1A and melanoma.